Christopher Hanyoung Lieu

机构：University of Colorado Cancer Center, University of Colorado Anschutz, University of Colorado Denver · ORCID：0000-0002-4852-4642

发表论文 392 篇 · 总被引 11261 次 · h-index 45

代表论文

NCI9673 (Part B): ETCTN Randomized Phase II Study of Nivolumab With or Without Ipilimumab in Refractory, Metastatic Squamous Cell Carcinoma of the Anal Canal (2026 · Journal of Clinical Oncology · 被引 7)
From Early Detection To Advanced Therapies: How Circulating Tumor DNA Is Transforming the Care of Colorectal Cancer (2025 · Current Oncology Reports · 被引 6)
Phase II Clinical Trial and Preclinical Evaluation of a Novel CD47 Blockade Combination in Refractory Microsatellite-Stable Metastatic Colorectal Cancer (2025 · Cancer Research Communications · 被引 4)
A Fluorescence Resonance Energy Transfer-Based Assay Targeting Tumor-Derived Extracellular Vesicles for Highly Specific Pancreatic Cancer Detection (2025 · ACS Nano · 被引 3)
A framework to evaluate surrogate endpoints at the trial level: analysis in colorectal cancer (2026 · JNCI Journal of the National Cancer Institute · 被引 1)
Survival and treatment trends in BRCA-mutated metastatic pancreatic adenocarcinoma. (2026 · Journal of Clinical Oncology · 被引 1)